Bio-Rad Laboratories, Inc.
NYSE · us_market
No AI summary generated yet for this ticker.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
On May 18, 2026, Elliott Investment Management disclosed a significant stake in Bio-Rad Laboratories and began pressing for changes to improve shareholder outcomes, focusing in part on the company’s large holding in Sartorius, valued at about US$5.00 billion. An interesting angle is that the market now values Bio-Rad’s Sartorius stake at nearly the company’s entire market value, raising questions about how much credit investors are giving to Bio-Rad’s core operating business. With Elliott’s...
On May 18, 2026, Elliott Investment Management disclosed a significant stake in Bio-Rad Laboratories and began pressing for changes to improve shareholder outcomes, focusing in part on the company’s large holding in Sartorius, valued at about US$5.00 billion. An interesting angle is that the market now values Bio-Rad’s Sartorius stake at nearly the company’s entire market value, raising questions about how much credit investors are giving to Bio-Rad’s core operating business. With Elliott’s...
Elliott reportedly built a sizable Bio-Rad stake as the life-science tools supplier trades far below its late-2021 peak.
Elliott reportedly built a sizable Bio-Rad stake as the life-science tools supplier trades far below its late-2021 peak.
Bio-Rad Laboratories, Inc. (BIO) RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 8:30 AM EDTCompany ParticipantsRoop Lakkaraju -...
The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.45%. June E-mini S&P futures (ESM26 ) fell -0.12%, and June E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.45%. June E-mini S&P futures (ESM26 ) fell -0.12%, and June E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.57%. June E-mini S&P futures (ESM26 ) are down -0.28%, and June E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.57%. June E-mini S&P futures (ESM26 ) are down -0.28%, and June E-mini Nasdaq futures...
Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle.
The S&P 500 Index ($SPX ) (SPY ) today is up +0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM26 ) are up +0.10%, and June E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM26 ) are up +0.10%, and June E-mini Nasdaq futures...
Healthcare stocks were declining pre-bell Monday, with the State Street Health Care Select Sector SP
Healthcare stocks were declining pre-bell Monday, with the State Street Health Care Select Sector SP
Nasdaq sinks 1.1% as AMAT, MU, ORCL and Vertiv crater on AI capex jitters, while WTI tops $106 and the 10-year yield hovers near 4.6% on stalled US-Iran talks.
TOYO shares rose 13.7% after beating earnings expectations. Other top gainers include JLHL, RAMP, HIVE, TE, AUTL, GENI, BRC, BIO, BL, RBLX, ZETA, and D.
https://www.wsj.com/business/deals/activist-elliott-builds-big-stake-in-life-science-tools-supplier-bio-rad-c99b23fa
Elliott also has a stake in German lab-equipment supplier Sartorius, where Bio-Rad is also an investor.
Activist investor Elliott InvestmentManagement has built a sizeable stake in U.S. diagnosticssupplier Bio-Rad Laboratories, and plans to push thecompany to boost its underperforming stock price,...
Activist investor Elliott InvestmentManagement has built a sizable stake in Bio-Rad Laboratoriesand plans to push the supplier of life-science tools anddiagnostics products to boost its...
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-30upcoming | 1.75 | — | — |
| 2026-04-30 | 1.99 | 1.89 | -4.79% |
| 2026-02-12 | 2.70 | 2.51 | -7.04% |
| 2025-10-29 | 1.93 | 2.26 | +16.97% |
| 2025-07-31 | 1.75 | 2.61 | +49.46% |
| 2025-05-01 | 1.78 | 2.54 | +42.51% |
| 2025-02-13 | 2.88 | 2.90 | +0.55% |
| 2024-10-30 | 1.18 | 2.01 | +70.83% |
| 2024-08-01 | 2.02 | 3.11 | +54.29% |
| 2024-05-07 | 2.14 | 2.29 | +7.12% |
| 2024-02-15 | 2.87 | 3.10 | +8.16% |
| 2023-10-26 | 2.81 | 2.33 | -17.17% |
| 2023-08-03 | 2.68 | 3.00 | +11.98% |
| 2023-05-04 | 3.48 | 3.34 | -3.94% |
| 2023-02-16 | 3.44 | 3.31 | -3.76% |
| 2022-10-27 | 2.77 | 2.60 | -6.00% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BIO | +21.80% | +11.52% | +3.13% | +37.70% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +18.83% | +16.16% | +6.58% | +25.01% |